Andrii Obrizan

Andrii Obrizan serves as CEO at Darnytsia Pharmaceutical Company. Darnytsia Pharmaceutical Company operates in the pharmaceuticals sector with approximately 400.0 employees.

Industry & Role Insights

• • MessageCEO tracks 1,288 executives in the pharmaceuticals sector.
• • Our database includes 201,469 c suite-level executives.

Cloudflare DNS ElasticEmail Outlook CloudFlare Hosting Shutterstock Google Dynamic Remarketing Google Maps Google Tag Manager Mobile Friendly Google Font API Google Places DoubleClick Conversion reCAPTCHA Hotjar DoubleClick SAP Azure Devops SAP Analytics Cloud Databricks AI

pharmaceutical manufacturing medications healthcare cardiology neurology pain management gmp certification analgesics paracetamol ibuprofen orodispersible tablets research patients medical institutions educational hub psychotrauma ptsd life quality improvement innovation affordable medicines quality assurance clinical practice sustainable development product development export hospital sales otc products rx sales digital transformation medical affairs regulatory compliance pharmacovigilance logistics corporate communications health education pharmacy pharmaceutical guide social responsibility charity initiatives business ethics employee development leadership partnership market leadership sales strategy production technology consumer health innovation in healthcare availability of medicines pharmaceuticals medical health care health wellness & fitness hospital & health care sustainability environmental services renewables & environment international trade & development public relations & communications

YM

Yathendra Madineni Chief Executive Officer at 4C Pharma Solutions

RB

Ronan Brown Chief Operating Officer at 4G Clinical

HK

Hitoshi Kamiya Chief Executive Officer at A2 Healthcare Corporation

LJ

Lars Jensen CEO at A-apoteket

TL

Tien Lee CEO at Aardvark Therapeutics, Inc.

Outreach Guidance — pharmaceuticals Sector

Executives like Andrii Obrizan in the pharmaceuticals sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Darnytsia Pharmaceutical Company.

Andrii Obrizan's Position in the MessageCEO Database

• •Andrii Obrizan is 1 of 1 verified executive contact we track at Darnytsia Pharmaceutical Company.
• •1,240 verified executive contacts in pharmaceuticals are in the MessageCEO database.
• •7 verified contacts work at pharmaceuticals companies in the 400.0 employee range (same size as Darnytsia Pharmaceutical Company).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.

How do I reach Andrii Obrizan directly?

Andrii Obrizan's verified email address is available to MessageCEO Pro subscribers. They currently serve as CEO at Darnytsia Pharmaceutical Company. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Andrii Obrizan work for?

Andrii Obrizan is CEO at Darnytsia Pharmaceutical Company, a company in the pharmaceuticals sector with 400.0 employees.

Can I pitch or sell to Andrii Obrizan?

As CEO at Darnytsia Pharmaceutical Company, Andrii Obrizan is a key decision-maker in the pharmaceuticals sector. MessageCEO Pro gives you verified email to reach Andrii Obrizan directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Andrii Obrizan in?

Andrii Obrizan works in the pharmaceuticals industry as CEO at Darnytsia Pharmaceutical Company. MessageCEO provides verified contact information for executives across all major industries.

Is Andrii Obrizan's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Andrii Obrizan's profile is kept up-to-date with the latest available information.

Last updated: July 21, 2026